Physician profile
Lloyd J Kellam
NPI 1851386114
$3,210.27
in general payments reported to CMS, 2019-2025
19 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $377 · 2021: $212 · 2022: $137 · 2023: $598 · 2024: $392 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $699.70 | 2019-2025 | |
| Pfizer INC. | $424.05 | 2019-2025 | |
| Amgen INC. | $297.37 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $266.46 | 2019-2023 | Camzyos, Eliquis |
| Medtronic, INC. | $198.32 | 2021-2023 | Corevalve Evolut R |
| Lexicon Pharmaceuticals, INC. | $190.41 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $167.91 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $167.52 | 2019-2020 | |
| Boston Scientific Corporation | $160.56 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $143.97 | 2019-2020 | |
| Medtronic Vascular, INC. | $106.46 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.17 | 2019-2024 | Jardiance |
| Scpharmaceuticals INC. | $75.75 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.79 | 2019-2020 | |
| Abbott Laboratories | $55.93 | 2023 | Jot Dx, Aveir |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $44.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2022-2023 | Brilinta |
| Astellas Pharma US INC | $16.29 | 2019 | |
| Emd Serono, INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Kellam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.